Serum prolidase level in ankylosing spondylitis: low serum levels as a new potential gold standard b...
Serum prolidase level in ankylosing spondylitis: low serum levels as a new potential gold standard biomarker for disease activity
About this item
Full title
Author / Creator
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Ankylosing spondylitis (AS) is a chronic inflammatory disorder that mainly affects the sacroiliac joints and axial skeleton. The aim of this study was to assess serum prolidase level (SPL) and its association with disease activity in patients with AS. This prospective study included 75 AS patients. Thirty age- and gender-matched healthy controls we...
Alternative Titles
Full title
Serum prolidase level in ankylosing spondylitis: low serum levels as a new potential gold standard biomarker for disease activity
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1826730724
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1826730724
Other Identifiers
ISSN
0172-8172
E-ISSN
1437-160X
DOI
10.1007/s00296-016-3536-x
